BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
9.09
-0.04 (-0.44%)
Mar 13, 2026, 4:00 PM EDT - Market closed
BBOT Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
|---|
| 373.69 | 30.85 | - | - |
| 51.77 | 124.78 | - | - |
Cash & Short-Term Investments | 425.46 | 155.63 | - | - |
| 173.38% | - | - | - |
| 0.39 | 0.08 | - | - |
| 6.55 | 2.98 | - | - |
| 432.4 | 158.69 | - | - |
Net Property, Plant & Equipment | 3.29 | 0.49 | - | - |
| 12.7 | 5.12 | 0.33 | 0.14 |
|
| 1.37 | 3.07 | 0.02 | - |
| 32.37 | 12.75 | - | - |
Current Portion of Leases | 0.52 | - | - | - |
Other Current Liabilities | 0.77 | 3.75 | 0.38 | 0.17 |
Total Current Liabilities | 35.04 | 19.58 | 0.4 | 0.17 |
| 2.24 | - | - | - |
Total Long-Term Liabilities | 2.24 | - | - | - |
|
| 0.01 | - | 0 | 0 |
Additional Paid-in Capital | 767.64 | 43.54 | 0.02 | 0.02 |
Accumulated Other Comprehensive Income | 0.02 | 0.35 | - | - |
| -356.57 | -222.52 | -0.09 | -0.05 |
| - | 323.36 | - | - |
| 411.1 | -178.64 | -0.06 | -0.02 |
Total Liabilities & Equity | 448.38 | 164.3 | 0.33 | 0.14 |
| 2.77 | 0 | 0 | 0 |
| 422.69 | 155.63 | -0 | -0 |
| 171.60% | - | - | - |
| 13.57 | 12061.61 | - | - |
| 411.1 | -178.64 | -0.06 | -0.02 |
| 13.20 | -13844.61 | -0.02 | -0.01 |
| 411.1 | -178.64 | -0.06 | -0.02 |
Tangible Book Value Per Share | 13.20 | -13844.61 | -0.02 | -0.01 |
Updated Dec 31, 2025. Data Source:
Fiscal.ai. Standard template.
Financial Sources.